Literature DB >> 12007627

Urocortin.

David S Latchman1.   

Abstract

Urocortin (Ucn) is a 40 amino acid peptide which is closely related to corticotrophin-releasing factor (CRF). It is expressed in specific regions of the brain but is also detectable in other organs notably the heart. Although some of the effects of Ucn in the nervous system such as enhanced anxiety and activity mimic those of CRF, Ucn is a much more potent suppressor of appetite/feeding behaviour. Moreover, Ucn has much more potent effects on the cardiovascular system than CRF, including enhanced cardiac contractility/heart rate and enhanced resistance of cardiac cells to injury induced, for example, by ischaemia/reperfusion. This suggests Ucn may play a key role in the response of the cardiovascular system to stress. In addition, Ucn represents a novel cardioprotective agent which may be of therapeutic use in treating the damaging effects of cardiac ischaemia and subsequent reperfusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007627     DOI: 10.1016/s1357-2725(02)00011-0

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  14 in total

1.  Effect of Urocortin on strength and microarchitecture of osteopenic rat femur.

Authors:  Mohammad Tezval; Silja Hansen; Ulrich Schmelz; Marina Komrakova; Klaus Michael Stuermer; Stephan Sehmisch
Journal:  J Bone Miner Metab       Date:  2014-03-16       Impact factor: 2.626

2.  Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditions.

Authors:  Manuela De Michele; Omar Touzani; Alan C Foster; Cesare Fieschi; Giuliano Sette; James McCulloch
Journal:  Exp Brain Res       Date:  2005-04-28       Impact factor: 1.972

Review 3.  Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.

Authors:  Emily G Lowery; Todd E Thiele
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

4.  Urocortin I inhibits the effects of ghrelin and neuropeptide Y on feeding and energy substrate utilization.

Authors:  Paul J Currie; Christine D Coiro; Raya Duenas; Janet L Guss; Aaisha Mirza; Neta Tal
Journal:  Brain Res       Date:  2011-04-18       Impact factor: 3.252

5.  Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.

Authors:  Ji Li; Dake Qi; Haiying Cheng; Xiaoyue Hu; Edward J Miller; Xiaohong Wu; Kerry S Russell; Nicole Mikush; Jiasheng Zhang; Lei Xiao; Robert S Sherwin; Lawrence H Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 6.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

Review 7.  Role of urocortin in pregnancy: An update and future perspectives.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Agnese Maria Chiara Rapisarda; Maria Giovanna Scarale; Francesco Corrado; Pietro Cignini; Salvatore Butticè; Diego Rossetti
Journal:  World J Clin Cases       Date:  2016-07-16       Impact factor: 1.337

8.  Localization and functional roles of corticotropin-releasing factor receptor type 2 in the cerebellum.

Authors:  Natalia V Gounko; Albert Gramsbergen; Johannes J L van der Want
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

9.  Urocortin in second trimester amniotic fluid: its role as predictor of preterm labor.

Authors:  C Iavazzo; K Tassis; D Gourgiotis; M Boutsikou; S Baka; D Hassiakos; C Vogiatzi; L Florentin-Arar; A Malamitsi-Puchner
Journal:  Mediators Inflamm       Date:  2009-11-04       Impact factor: 4.711

10.  Differentiation dependent expression of urocortin's mRNA and peptide in human osteoprogenitor cells: influence of BMP-2, TGF-beta-1 and dexamethasone.

Authors:  Mohammad Tezval; Hossein Tezval; Klaus Dresing; Ewa Klara Stuermer; Martina Blaschke; Klaus Michael Stuermer; Heide Siggelkow
Journal:  J Mol Histol       Date:  2009-12-01       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.